Cargando…
A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID β and Reduce In Vitro Neurotoxicity
Galantamine is a natural alkaloid extracted from the Amaryllidaceae plants and is used as the active ingredient of a drug approved for the treatment of the early stages of Alzheimer’s disease. It mainly acts as an acetylcholinesterase (AChE) inhibitor, increasing concentrations of the acetylcholine...
Autores principales: | Kola, Arian, Lamponi, Stefania, Currò, Francesco, Valensin, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916559/ https://www.ncbi.nlm.nih.gov/pubmed/36768823 http://dx.doi.org/10.3390/ijms24032500 |
Ejemplares similares
-
Novel Perspective on Alzheimer’s Disease Treatment: Rosmarinic Acid Molecular Interplay with Copper(II) and Amyloid β
por: Kola, Arian, et al.
Publicado: (2020) -
Protective Effect of Galantamine against Doxorubicin-Induced Neurotoxicity
por: Alsikhan, Rawan S., et al.
Publicado: (2023) -
In Vitro Inhibition of Alphaviruses by Lycorine
por: Li, Na, et al.
Publicado: (2021) -
Bioinorganic Chemistry of Micronutrients Related to Alzheimer’s and Parkinson’s Diseases
por: Kola, Arian, et al.
Publicado: (2023) -
Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
por: Tassone, Giusy, et al.
Publicado: (2021)